These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8635122)

  • 21. Results of repeated hepatectomy for recurrent hepatocellular carcinoma.
    Ochiai T; Sonoyama T; Kikuchi S; Konishi H; Kitagawa M; Okayama T; Ichikawa D; Ueda Y; Otsuji E; Yamagishi H
    Hepatogastroenterology; 2007; 54(75):858-61. PubMed ID: 17591079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
    Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
    Cucchetti A; Piscaglia F; Caturelli E; Benvegnù L; Vivarelli M; Ercolani G; Cescon M; Ravaioli M; Grazi GL; Bolondi L; Pinna AD
    Ann Surg Oncol; 2009 Feb; 16(2):413-22. PubMed ID: 19034578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization.
    Kamiyama T; Nakanishi K; Yokoo H; Kamachi H; Tahara M; Suzuki T; Shimamura T; Furukawa H; Matsushita M; Todo S
    Ann Surg Oncol; 2009 Jun; 16(6):1560-71. PubMed ID: 19259739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatic resection and transplantation for hepatocellular carcinoma in patients with cirrhosis].
    Gugenheim J; Baldini E; Casaccia M; Ouzan D; Saint-Paul MC; Mouiel J
    Gastroenterol Clin Biol; 1997; 21(8-9):590-5. PubMed ID: 9587497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy.
    Seki T; Wakabayashi M; Nakagawa T; Imamura M; Tamai T; Nishimura A; Yamashiki N; Okamura A; Inoue K
    Cancer; 1999 Apr; 85(8):1694-702. PubMed ID: 10223562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma.
    Chen MF; Jeng LB; Lee WC; Chen TC
    Surgery; 1998 May; 123(5):554-9. PubMed ID: 9591008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis.
    Ueno S; Tanabe G; Yoshida A; Yoshidome S; Takao S; Aikou T
    Cancer; 1999 Jul; 86(2):248-54. PubMed ID: 10421260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver.
    Chang CH; Chau GY; Lui WY; Tsay SH; King KL; Wu CW
    Arch Surg; 2004 Mar; 139(3):320-5; discussion 326. PubMed ID: 15006892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic resection for hepatocellular carcinoma in severely cirrhotic livers.
    Kaibori M; Matsui Y; Kitade H; Kwon AH; Kamiyama Y
    Hepatogastroenterology; 2003; 50(50):491-6. PubMed ID: 12749254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognosis of patients with hepatocellular carcinoma of multicentric origin.
    Okusaka T; Okada S; Nose H; Ishii H; Nakasuka H; Nakayama H; Nagahama H; Yoshimori M; Shimada K; Yamamoto J; Takayama T; Kosuge T; Yamasaki S; Sakamoto M; Hirohashi S
    Hepatogastroenterology; 1996; 43(10):919-25. PubMed ID: 8884314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three decades' experience in surgery of hepatocellular carcinoma.
    Tang ZY; Yu YQ; Zhou XD; Yang BH; Lin ZY; Lu JZ; Ma ZC; Ye SL; Liu KD
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():126-33. PubMed ID: 9210895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
    Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
    Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis of early hepatocellular carcinoma after hepatic resection.
    Maeda T; Shimada M; Harimoto N; Tsujita E; Aishima S; Tanaka S; Shirabe K; Maehara Y
    Hepatogastroenterology; 2008; 55(85):1428-32. PubMed ID: 18795705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma.
    Tanaka K; Shimada H; Matsumoto C; Matsuo K; Nagano Y; Endo I; Togo S
    Surgery; 2008 May; 143(5):607-15. PubMed ID: 18436008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation.
    Kubo S; Kinoshita H; Hirohashi K; Tanaka H; Tsukamoto T; Hamba H; Shuto T; Yamamoto T; Ikebe T; Wakasa K
    Hepatogastroenterology; 1999; 46(30):3212-5. PubMed ID: 10626188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
    Figueras J; Jaurrieta E; Valls C; Benasco C; Rafecas A; Xiol X; Fabregat J; Casanovas T; Torras J; Baliellas C; Ibañez L; Moreno P; Casais L
    Hepatology; 1997 Jun; 25(6):1485-9. PubMed ID: 9185772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
    Zou WL; Zang YJ; Chen XG; Shen ZY
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma?
    Chiu JH; Wu LH; Kao HL; Chang HM; Tsay SH; Loong CC; Chau GY; Lui WY
    Hepatology; 1993 Jul; 18(1):96-102. PubMed ID: 8392030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.